Back to ISPOR Asia Pacific Summit 2026 Home
  Register
  • About
    • Why Attend
    • Registration Information
    • Marketing Kit
    • Attendee Resources
  • Short Courses
    • Short Courses
    • View All Short Courses
  • Program
    • Program
    • Learning Formats
    • Posters
    • Program Committee
  • Presenter Information
    • Speaker Resources
    • Poster Resources
  • Hotel & Venue
    • Hotel & Venue Information
    • Discover Bangkok 
large-circle

ISPOR Asia Pacific Summit 2026

6-8 September

  • Home
  • Events
  • Upcoming Conferences & Events
  • ISPOR Asia Pacific Summit 2026
  • Program
  • Program
  • Presentation
  • ACUPUNCTURE RECOMMENDATIONS IN ONCOLOGY CLINICAL PRACTICE GUIDELINES

    Jul 9, 2026, 19:56 PM
  • EVALUATION OF THE EFFECTIVENESS, COSTS, AND COST-EFFECTIVENESS OF A DEEP LEARNING-BASED TRACHEAL INTUBATION TRAINING SYSTEM

    Jul 9, 2026, 19:56 PM
  • HEALTH ECONOMIC EVALUATION OF PANCREATIC CANCER RISK CONTROL USING PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M) IN BRCA1/2 PATHOGENIC VARIANT CARRIERS

    Jul 9, 2026, 19:56 PM
  • PATIENT CHARACTERISTICS AND HEALTHCARE RESOURCE UTILIZATION ASSOCIATED WITH SEROTYPE 3 AND EMERGING SEROTYPE 15A PNEUMOCOCCAL DISEASE IN HONG KONG FROM 2007-2024

    Jul 9, 2026, 19:56 PM
  • PROJECTED INCIDENCE AND ECONOMIC BURDEN OF STROKE IN CHINA, 2022-2050

    Jul 9, 2026, 19:56 PM
  • OPPORTUNITIES AND PITFALLS WHEN DELPHI EXPERT CONSENSUS SUBSTITUTES FOR MISSING EVIDENCE IN RARE DISEASES: A TARGETED LITERATURE REVIEW...

    Jul 9, 2026, 19:56 PM
  • BRIDGING THE INSULIN GAP: A STUDY OF AVAILABILITY AND ACCESSIBILITY IN KALYAN (WEST), INDIA

    Jul 9, 2026, 19:56 PM
  • ADVANCING VALUE-BASED HEALTHCARE THROUGH VALUE-BASED PROCUREMENT: POLICY LANDSCAPE AND IMPLEMENTATION GAPS IN INDONESIA

    Jul 9, 2026, 19:54 PM
  • FROM REGIONAL PRINCIPLES TO LOCAL IMPLEMENTATION: HOW CHINA’S NHSA AND JAPAN’S C2H GUIDELINES BUILD ON THE ASIA-PACIFIC REALISE GUIDANCE FOR REAL-WORLD EVIDENCE USE IN HTA

    Jul 9, 2026, 19:54 PM
  • ASSESSING THE FEASIBILITY OF INDIRECT COMPARISON OF LUVOMETINIB VERSUS SELUMETINIB IN THE TREATMENT FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 IN CHINA...

    Jul 9, 2026, 19:54 PM
  • COST-EFFECTIVENESS OF PRASUGREL VERSUS TICAGRELOR IN ACUTE CORONARY SYNDROME: AN INDIAN PERSPECTIVE

    Jul 9, 2026, 19:54 PM
  • REGENERATIVE MEDICINE IN CHRONIC AND COMPLEX WOUNDS. PRELIMINARY ANALYSIS OF ECONOMIC IMPACT REVIEW DATA FROM HEOR IN A PRIVATE HEALTH SYSTEM IN BRAZIL/ LATAM/ LMIC

    Jul 9, 2026, 19:54 PM
  • REGULATORY AND HTA ACCEPTANCE OF EXTERNAL CONTROL ARMS: EVIDENCE STANDARDS AND TARGETED APPLICATIONS IN ASTHMA

    Jul 9, 2026, 19:54 PM
  • SOCIAL RETURN ON INVESTMENT (SROI) FOR EXPANDING YOUTH MENTAL HEALTH SCREENING: A DISCRETE CHOICE EXPERIMENT...

    Jul 9, 2026, 19:54 PM
  • COST-EFFECTIVENESS ANALYSIS OF CETUXIMAB FOR THE TREATMENT OF HEAD AND NECK CANCERS IN INDIA...

    Jul 9, 2026, 19:54 PM
  • OSTEOPOROSIS TREATMENT WITH BIOSIMILARS IN MALAYSIA AND THAILAND: A BUDGET IMPACT ANALYSIS

    Jul 9, 2026, 19:54 PM
  • IMPACTS OF PROVINCIAL PORTABILITY POLICY ON HEALTHCARE UTILIZATION AND OUT-OF-POCKET EXPENDITURES IN VIETNAM...

    Jul 9, 2026, 19:54 PM
  • ASSESSING THE RISK OF DRUG LAUNCH DELAYS IN AUSTRALIA UNDER US MOST FAVORED NATION PRICING MODELS

    Jul 9, 2026, 19:54 PM
  • RESPONSIBLE USE OF AGENTIC ARTIFICIAL INTELLIGENCE IN HEALTH ECONOMICS AND OUTCOMES RESEARCH: A RISK-STRATIFIED GOVERNANCE FRAMEWORK

    Jul 9, 2026, 19:54 PM
  • HIDDEN TRADE-OFFS IN HEALTHCARE AFFORDABILITY: HOW FINANCING RULES SHAPE RESOURCE ALLOCATION AMONG SANDWICHED HOUSEHOLDS IN SINGAPORE

    Jul 9, 2026, 19:54 PM
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7 (current)
  • 8
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • AI Policy
  • Antitrust Compliance
  • Code of Ethics
  • Cookie Policy
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy
  • Terms and Conditions

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group